Moderna ($MRNA) issued a shareholder letter dated Jan 5, 2026; the letter is attached as Exhibit 99.1 and…
Filed with the SEC on · Summarized by InvestorsBot
Moderna ($MRNA) issued a shareholder letter dated Jan 5, 2026; the letter is attached as Exhibit 99.1 and disclosed under Regulation FD. 📣📝 #RegulationFD #SEC
The letter/Exhibit 99.1 were furnished (not “filed”) — not subject to Section 18 liabilities and not incorporated by reference except as expressly stated. ⚖️ $MRNA #SEC #RegulationFD
Investors: review Exhibit 99.1 for the full shareholder letter (Jan 5, 2026). Item 7.01 only furnishes the letter and legal notice; no additional material details disclosed here. 🔍 $MRNA #Investors #Moderna